Genre
- Journal Article
Alterations in cellular growth are important in the progression of malignant disease. Cell growth regulation by tumour promoters can be complex. The present study demonstrates a novel link between alterations in phorbol ester tumour promoter mediated regulation during malignant conversion and the expression of ornithine decarboxylase and S-adenosylmethionine decarboxylase, key rate-limiting and regulatory activities in the biosynthesis of polyamines. H-ras-transformed mouse 10 T 1/2 cell lines exhibiting increasing malignant potential were investigated for possible phorbol ester tumour promoter mediated changes in ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (SAMDC) gene expression. Selective induction of ODC and SAMDC gene expression was observed, since in contrast to nontransformed parental 10 T1/2 cells, ras-transformed cells capable of benign tumour formation (NR3 cells) and ras-transformed cells capable of metastasis formation (C2 cells) exhibited marked alterations in the levels of ODC and SAMDC gene expression. Increased ODC gene and SAMDC gene expression in response to phorbol-12-myristate-13-acetate (PMA) treatment was found to involve transcriptional events in both NR3 cells and in C2 cells. Post-transcriptional events also played a role in the regulation of ODC gene expression in NR3 cells and in C2 cells, and in the regulation of SAMDC gene expression in C2 cells but not in NR3 cells. In NR3 cells, alterations in ODC and in SAMDC gene expression was an event requiring de novo protein synthesis, whereas in highly malignant C2 cells, protein synthesis inhibition following cycloheximide treatment in cooperation with PMA resulted in an augmentation of both ODC and SAMDC gene expression. Evidence is presented to suggest that the PMA-mediated alterations in ODC and in SAMDC gene expression in NR3 cells and in C2 cells involved protein kinase C - mediated events. The status of the cellular polyamine levels was also an important determinant of the PMA-mediated alterations that occurred in ODC and in SAMDC expression in these H-ras transformed cells. Collectively, these results suggest that PMA can modulate ODC and SAMDC expression in H-ras transformed cells and that the mechanisms involved in the PMA- mediated regulation of ODC and SAMDC gene expression changes as a function of H-ras mediated cellular transformation and malignant progression. This study further suggests a mechanism of PMA stimulation of transformed cells wherein early alterations in the regulatory control of ODC and SAMDC gene expression are important and critical.
Univ Toronto, St Michaels Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5B 1A6, Canada.; Hurta, RAR, Univ Toronto, St Michaels Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5B 1A6, Canada.
OTTAWA; RESEARCH JOURNALS, MONTREAL RD, OTTAWA, ONTARIO K1A 0R6, CANADA
NATL RESEARCH COUNCIL CANADA
PT: J; CR: AUVINEN M, 1992, NATURE, V360, P355 AUVINEN M, 1997, J NATL CANCER I, V89, P533 BIELECKI D, 2000, CELL SIGNAL, V12, P451 BUTLER AP, 1991, EXP CELL RES, V194, P56 CELANO P, 1989, J BIOL CHEM, V264, P8922 EDWARDS DR, 1992, EMBO J, V11, P2415 EGAN SE, 1987, MOL CELL BIOL, V7, P830 HEBY O, 1989, PHYSL POLYAMINES, P83 HEBY O, 1990, TRENDS BIOCHEM SCI, V15, P153 HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993 HURTA RAR, 1993, J CELL PHYSIOL, V156, P272 HURTA RAR, 1994, J CELL PHYSIOL, V161, P383 HURTA RAR, 1995, J CELL BIOCHEM, V57, P543 HURTA RAR, 1996, J CELL BIOCHEM, V60, P572 HURTA RAR, 1999, FASEB J S 1, V13, A520 HURTA RAR, 2000, IN PRESS J CELL BIOC JANNE J, 1991, ANN MED, V23, P241 KAHANA C, 1985, J BIOL CHEM, V260, P15390 KATZ A, 1987, MOL CELL BIOL, V7, P2641 KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548 MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55 MUKHERJEE R, 1987, J BIOL CHEM, V262, P13697 NISHIZUKA Y, 1986, SCIENCE, V233, P305 NISHIZUKA Y, 1995, FASEB J, V9, P484 OLSON EN, 1986, MOL CELL BIOL, V6, P2792 PEGG AE, 1982, AM J PHYSIOL, V243, P212 PEGG AE, 1986, BIOCHEM J, V234, P249 PEGG AE, 1988, CANCER RES, V48, P759 PEGG AE, 1988, ISI ATLAS-BIOCHEM, V25, P11 PEGG AE, 1992, PHARMACOL THERAPEUT, V56, P359 PHILLIPS DR, 1986, BIOCHEMISTRY-US, V25, P7355 RUSSELL DH, 1968, P NATL ACAD SCI USA, V60, P1420 SERTICH GJ, 1987, BIOCHEM BIOPH RES CO, V143, P424 SHANTZ LM, 1992, BIOCHEM J 2, V288, P511 SOININEN T, 1996, BIOCHEM J 1, V316, P273 SUNKARA PS, 1987, CANCER RES, V47, P933 TABIB A, 1998, INT J BIOCHEM CELL B, V30, P135 TABIB A, 1999, INT J BIOCHEM CELL B, V31, P1289 TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749 TAMM I, 1978, ADV VIRUS RES, V22, P187 VERMA AK, 1987, INHIBITION POLYAMINE, P249 WANG JY, 1992, AM J PHYSIOL, V263, G494 YOSHIDA M, 1992, CANCER RES, V52, P6671 YOUNG S, 1987, BIOCHEM J, V244, P775; NR: 44; TC: 5; J9: BIOCHEM CELL BIOL; PG: 13; GA: 395RZ
Source type: Electronic(1)
Language
- English
Subjects
- MALIGNANT TRANSFORMATION
- malignant progression
- PMA
- HEPATOMA-CELLS
- POLYAMINES
- INHIBITOR
- FIBROBLASTS
- ornithine decarboxylase
- growth
- Cell Biology
- S-adenosylmethionine decarboxylase
- MESSENGER-RNA
- TRANSCRIPTION
- PROTEIN-KINASE-C
- FACTOR-BETA(1)
- Biochemistry & Molecular Biology
- GENE-EXPRESSION